HCP|NETWORK.

Specialties

cardiology child & adolescent health clinical medicine consumer health information updates dermatology diabetes & endocrinology drug information soundcast in clinical oncology (d.i.s.c.o.)drug safety podcasts endocrinology gastroenterology gastroenterology & hepatology general medicine geriatrics/aging haematology hematology/oncology hiv infectious disease infectious diseases medical journal medical news microbe / infectious research nephrology neurology oncology pediatrics planetary health psychiatry psychiatry and behavioral health public health pulmonary medicine regional health – americas regional health – europe regional health – southeast asia respiratory medicine rheumatology surgery telemedicine / digital health what's new: drugs what's new: vaccines, blood and biologics women's health

Sources

bmj medicine cell.com diabetes journals diabetesdad endocrineethicsblog endocrinenews fda https://wwwnc.cdc.gov/journal of the american medical association nature medicine nature medicine's advance online publication (aop) table of contents.nlm offers rss feeds nlm update rss feeds oxford university press phys.org pnas pnas podcast pubmed rxnav news sage journals the lancet the new england journal of medicine wiley

HCP|NETWORK.

Specialties

Sources

HCP Network

Trusted Medical Platform for Healthcare Professionals

A secure, verified platform exclusively for healthcare professionals. Delivering trusted medical news, provider insights, and professional resources with confidence.

HCP-Only Access

|

Privacy Protected

Quick Links

Professional Resources

Privacy Policy About Us

Verified HCP Portal

Licensed Healthcare Professionals Only

We use cookies to enhance your experience. By continuing to browse, you agree to our use of cookies.

© 2026 HCP Network. All rights reserved. Healthcare Professional Use Only.

Digitoxin — A Reminder for Digoxin

article_img

29th Oct, 2025

Cardiology

The New England Journal of Medicine

Cardiac glycosides are among the oldest medications in cardiovascular care, prized for their actions as positive inotropic agents and modulators of atrioventricular conduction. In heart failure with reduced ejection fraction, their mechanistic rationale was so convincing that digitalis became a mainstay of treatment long before the initiation of large-scale trials...

Published By: The New England Journal of Medicine

Related Articles

Cardiology

15th Jan, 2026

Journal of the American Medical Association

Fever, Rash, and Dizziness in a 32-Year-Old

Cardiology

15th Jan, 2026

Journal of the American Medical Association

Expanding the Arsenal of Lipid-Lowering Therapies

Cardiology

22nd Dec, 2025

Journal of the American Medical Association

Sociodemographic Characteristics in Clinical Algorithms

Cardiology

15th Jan, 2026

Journal of the American Medical Association

Fatigue, Nausea, and Electrocardiogram Abnormalities

Cardiology

10th Dec, 2025

Journal of the American Medical Association

Mechanistic Insights Into Post-TAVR Atrioventricular Block

Cardiology

8th Dec, 2025

Journal of the American Medical Association

Evidence for Clinical Treatment Decisions Without Randomized Data

Cardiology

2nd Dec, 2025

Journal of the American Medical Association

Levosimendan and Weaning From VA-ECMO